Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS) Read more
Delhi Residents Seek Mental Health Support: Relationship Issues and Anxiety Top Concerns in the Age Group 26 to 40-year-olds Read more
SATB Launches Addressing The Twin Epidemics: Survivor Led Framework to Integrate Mental Health and TB Care Read more
68-Year-Old Brain-Dead from Pune Gives a New Lease of Life to Patient Suffering from Liver Disease Read more
Arya Vaidya Pharmacy Expands Product Portfolio, Strengthening Its Commitment to Holistic Health and Sustainability Read more
Strategic Philanthropy to Combat Cancer: WinZO and Tata Memorial Hospital Invest to set-up India’s first Gene Counseling facility Read more